Abstract
The present disclosure provides chemical compound derivatives of a class of biological lipid mediators known as endocannabinoids and methods of synthesizing the compositions. These compounds are useful for treating cancer, reducing inflammation, reducing platelet aggregation, and reducing angiogenesis.
Original language | English (US) |
---|---|
U.S. patent number | 11407728 |
Filing date | 9/20/18 |
State | Published - Aug 9 2022 |